Below is a list containing Midcap stocks which in the past 1 week gave positive stock returns; had their latest average SR+ score of minimum 7 which also improved by at least 1 point week on week; had a minimum of 4 analysts recommending the stock with a rating of “Strong Buy” or “Buy”; and had a positive upside potential returns in the coming 1 year period according to the mean price targets given by all the analysts covering the individual stocks.
Nifty Pharma, 4 others hit 52-week high since Iran war while Nifty fell 7%. Will the form continue?
Despite a challenging market backdrop fueled by geopolitical tensions and foreign fund outflows, five Indian sectors—Pharma, Energy, Defence, Capital Markets, and Metals—are showing remarkable strength.
May 25, 2026